About

I am a psychiatrist and a researcher. I was trained in Europe and in Canada and currently I practice in Toronto. My work, both clinical and research, is mainly focused on addictions and concurrent disorders, but as a practicing physician, as a researcher and simply as an inquisitive person, I have developed a strong interest in healthy living and fitness. I researched nutrition and tried various approaches to improve my own health and physique. I believe that over the course of the past 15-20 years I have accumulated enough experience and knowledge to start sharing it with others.

Dr.Sam's Health Project

Dr. Sam's Health project mission is to promote health and self-improvement through research and education.

There is an ocean of information on health, training, nutrition and well-being. In fact, there is so much data and the key facts are at times so distorted that it is virtually impossible for a non-professional to form an accurate and realistic approach to their living. As an MD and a researcher I have the skill set necessary to find and to properly analyze these data and to give you the answers to the questions that are important for you. At the same time, as a mental health professional I often find myself in a situation when I don't feel fully comfortable giving advice on nutrition and talking about physique as there is a lot of information that is either not strictly medical or not fully endorsed by mainstream medical regulating bodies and professional audiences such as low-carbohydrate diets or intermittent fasting. On top of that, there are millions of people who seek professional advice and guidance and it is simply impossible to consult them all individually. Even if I provide an excellent individual consultation to hundreds of people I will barely scratch the surface.

At Dr.Sam's Health we make a commitment to address this problem:

  • We will be researching the most relevant issues related to healthy living, nutrition and training.
  • We will analyze the information without bias and prejudice through a lens of a health care professional expertise and knowledge.
  • We will present it in a simple, yet comprehensive way so that anyone interested in these topics irrespectively to their line of work and education level would be able to gain the knowledge relevant to their goals.

We hope that such approach will help you to stay informed and to achieve your health and physique goals.

My valued moments... Personal and Professional

The Best Lecturer Award

In 2018 I received a very pleasant surprise – the Best Lecturer Award for teaching a course on multidisciplinary aspects of addiction at the University of Toronto. I've been facilitating this course for several years at the moment, and I was doing my best to nicely wrap up my clinical expertise and lots of academic, theoretical aspects of addiction into a very concise and memorable course. I was absolutely delighted to learn that my students ranked me as the best lecturer - a true honour and pleasure for an educator!

Left to right: Dr.Michael Chaiton, Course Director; Dr.Nigel Turner, a fellow Best Lecturer and an excellent researcher; Dr.Andriy V.Samokhvalov

My TEDx Talk

In 2016 I was honoured with an opportunity to present on TEDx platform. My talk was based on my expertise in treatment of depression concurrent with alcohol use disorder and on my work on the DA VINCI project. Undoubtedly, it was one amazing event that allowed for effacing the boundaries between clinical psychiatry, academic research and the general public. I enjoyed it a lot and I had a number of opportunities to talk to the event's attendees who spoke about their personal stories and shared their views on our health care system.

The DA VINCI Project

In 2015 I became a principal investigator for the DA VINCI project – we have received a provincial grant from ARTIC program to fund scaling up of a new treatment model for concurrent depression and alcohol use disorder, something I've been working on for a while by that moment. It was a tremendous achievement and a great opportunity to extend this treatment model to multiple locations across Ontario. Over the course of 22 months I was meeting with my colleagues in Academic and Community Hospitals and Family Health Teams. I've been teaching, advocating, collaborating... I can definitely say that this project required all my dedication and professionalism to see it through. And I and my team made it happen! We provided almost 400 patients with highly comprehensive treatment over the course of the project and even more after it was completed.

Making an acceptance speech at the HQO headquarters.

I received this award at the annual reception and dinner. What a day!

The Physician of the Year Award

In 2014 I received a Physician of the Year Award as a token of recognition of the impact of my clinical work, my support of education and innovation and for translating my research findings and academic expertise into clinical practice. It was a truly glorious moment for me! Just several years prior to that I wasn't even sure if I would be able to come to Canada, let alone being blessed with an opportunity to practice medicine so soon and receiving such an award! This meant a lot to me then, and it means a lot to me now. Moments like this are remarkable as they allow you to step away from your daily work and to reflect on you past, present and future.

Becoming a Canadian

It's my 10th Anniversary on April 29th, 2018 and I still remember the day when I became a landed immigrant. It was my very first visit to Canada – my far away land of new life and new opportunities. Despite my aspirations and excitement being very high, I had no clue what to expect. The only thing I was sure about – my new life was starting! It's been 10 years and I have learnt and seen a lot – I made new friends, I acquired and mastered new skills, moved several times... I learnt to ride a motorcycle and survived a pretty bad motorcycle accident, I became a competitive shooter, a physician of the year, a best lecturer... I led clinical projects and helped a lot of Canadians with their addictions and mental health problems... I learnt to think differently and I have reinvented myself over and over again. These were 10 very intense years and I am looking forward to seeing what will be around the corner.

A very touching moment - I came to the clinic the day after my Citizenship ceremony and my nurses distracted me for several minutes, while others decorated my office with Canadian symbols. It was a very warm signal of acceptance and a very Canadian gesture!

Publications, presentations and media appearances

    Peer-Reviewed Articles

  1. Samokhvalov AV., Probst C, Awan S, George TP, Le Foll B, Rehm J. Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study. BMC psychiatry 2018, 18(1):189. [PMID:29898697] doi:10.1186/s12888-018-1770-3.
    https://www.ncbi.nlm.nih.gov/pubmed/29898697
  2. Samokhvalov AV., Schütz C. Entwicklung, Implementierung und erste Studienergebnisse eines integrierten Versorgungspfads für Patienten mit kombinierten Alkoholkonsum- und depressiven Störungen: Erfahrungen aus Kanada. Suchtmedizin 2018, 20(1):12-13.
  3. Samokhvalov AV., Probst C, Rehm J. Glass-Box Testing the Centre for Addiction and Mental Health Integrated Care Pathway for Major Depressive and Alcohol Use Disorders: Is It More Than a Sum of Its Components? Canadian Journal of Addiction 2018, 9 (1):7-17. doi:10.1097/CXA.0000000000000011.
    https://journals.lww.com/cja/Abstract/2018/03000/Glass_Box_Testing_the_Centre_for_Addiction_and.2.aspx
  4. Minian N, Noormohamed A, Zawertailo L, Baliunas D, Giesbrecht N, Le Foll B, Rehm J, Samokhvalov AV., Selby PL. A method for co-creation of an evidence-based patient workbook to address alcohol use when quitting smoking in primary care: a case study. Research involvement and engagement 2018, 4(1):4. [PMID: 29445521] doi:10.1186/s40900-018-0086-2
    https://www.ncbi.nlm.nih.gov/pubmed/29445521
  5. Hendershot CS, Wardell JD, Samokhvalov AV., Rehm J. Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies. Addiction Biology 2017, 22(6):1515-27. [PMID: 27411969] doi:10.1111/adb.12425.
    https://www.ncbi.nlm.nih.gov/pubmed/27411969
  6. Samokhvalov AV., Awan S, George TP, Irving J, Le Foll B, Perrotta S, Probst C, Voore P, Rehm J. Integrated Care Pathway for Co-Occurring Major Depressive and Alcohol Use Disorders: Outcomes of the First Two Years. The American Journal on Addictions 2017, 26(6):602-9. [PMID: 28570773] doi:10.1111/ajad.12572.
    https://www.ncbi.nlm.nih.gov/pubmed/28570773
  7. Hassan A, Howe A, Samokhvalov AV., Le Foll B, George T. Management of Mood and Anxiety Disorders in Patients Receiving Opioid Agonist Therapy: Review and Meta-analysis, The American Journal on Addictions 2017, 26(6):551-63. [PMID: 28675762] doi:10.1111/ajad.12581.
    https://www.ncbi.nlm.nih.gov/pubmed/28675762
  8. Imtiaz S, Shield K, Roerecke M, Samokhvalov AV., Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: Meta-analyses and burden of disease. European Respiratory Journal 2017, 50(1). [PMID: 28705945] doi:10.1183/13993003.00216-2017.
    https://www.ncbi.nlm.nih.gov/pubmed/28705945
  9. Minian N, Baliunas D, Zawertailo L, Noormohamed A, Giesbrecht N, Hendershot C, Le Foll B, Rehm J, Samokhvalov AV., Selby P. Combining alcohol interventions with tobacco addictions treatment in primary care - the COMBAT study: A pragmatic cluster randomized trial. Implementation Science 2017, 12(1):65. doi:10.1186/s13012-017-0595-7.
    https://implementationscience.biomedcentral.com/articles/10.1186/s13012-017-0595-7
  10. Rehm J, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, Probst C, Roerecke M, Room R, Samokhvalov AV., Shield KD, Shuper PA. The relationship between different dimensions of alcohol use and the burden of disease - an update. Addiction 2017, 112(6):968-1001. [PMID: 28220587] doi:10.1111/add.13757.
    https://www.ncbi.nlm.nih.gov/pubmed/28220587
  11. Samokhvalov AV, Le Foll B. A 35-year-old woman with low mood and concerns about her alcohol use. CMAJ 2017, 189(8):E317-18. [PMID: 28246225] doi:10.1503/cmaj.160132.
    https://www.ncbi.nlm.nih.gov/pubmed/28246225
  12. Samokhvalov AV., Rehm J, Roerecke M. Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses. EBioMedicine 2015, 2(12):1996-2002. [PMID:26844279] doi:10.1016/j.ebiom.2015.11.023.
    https://www.ncbi.nlm.nih.gov/pubmed/26844279
  13. Samokhvalov AV., Rehm J. Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy. BMJ Case Reports 2015. Online Journal.  [PMID:26567239] doi:10.1136/bcr-2015-211954.
    https://www.ncbi.nlm.nih.gov/pubmed/26567239
  14. Awan S, Samokhvalov AV, Aleem N, Hendershot CS, Irving JA, Kalvik A, Lefebvre L, Le Foll B, Quilty L, Voore P. Development and Implementation of an Ambulatory Integrated Care Pathway for Major Depressive Disorder and Alcohol Dependence. Psychiatric Services 2015, 66(12):1265-7. [PMID: 26278235] doi:10.1176/appi.ps.201500115.
    https://www.ncbi.nlm.nih.gov/pubmed/26278235
  15. Samokhvalov AV., Selby P, Bondy SJ, Chaiton M, Ialomiteanu A, Mann R, Rehm J. Smokers who seek help in specialized cessation clinics: How special are they compared to smokers in general population? Journal of Smoking Cessation 2014, 9(2):76-84. doi:10.1017/jsc.2013.23.
    https://www.cambridge.org/core/journals/journal-of-smoking-cessation/article/smokers-who-seek-help-in-specialized-cessation-clinics-how-special-are-they-compared-to-smokers-in-general-population/E24BA497B43A5AB95FFADEDCE53A41F0
  16. Rehm J, Kailasapillai S, Larsen E, Rehm M, Samokhvalov AV., Shield KD, Roerecke M, Lachenmeier DW. A systematic review of unrecorded alcohol with a focus on prevalence of consumption and health. Addiction 2014, 109(6):880-93. [PMID: 24467748] doi:10.1111/add.12498
    https://www.ncbi.nlm.nih.gov/pubmed/24467748
  17. Chaiton M, Mercredy G, Rehm J, Samokhvalov AV. Tobacco retail availability and smoking behaviours among patients seeking treatment at a nicotine dependence treatment clinic. Tobacco Induced Diseases 2014, 12(1):19. [PMID:25745380] doi:10.1186/1617-9625-12-19
    https://www.ncbi.nlm.nih.gov/pubmed/25745380
  18. Samokhvalov AV., Paton-Gay CL, Balchand K, Rehm J. Phenibut dependence. BMJ Case Reports 2013; Online Journal. [PMID: 23391959] doi:10.1136/bcr-2012-008381.
    https://www.ncbi.nlm.nih.gov/pubmed/23391959
  19. Rehm J, Marmer S, Anderson P, Gual A, Kraus L, Nutt DJ, Room R, Samokhvalov AV., Scafato E, Trapencieris M, Wiers RW, Gmel G. Defining substance use disorders: Do we really need more than heavy use? Alcohol and alcoholism 2013, 48(6):633-640. [PMID: 23926213] doi:10.1093/alcalc/agt127
    https://www.ncbi.nlm.nih.gov/pubmed/23926213
  20. Rehm J, Samokhvalov AV., Shield KD. Global burden of alcoholic liver disease. Journal of Hepatology 2013, 591(1):160-8. [PMID:23511777] doi:10.1016/j.jhep.2013.03.007
    https://www.ncbi.nlm.nih.gov/pubmed/23511777
  21. Samokhvalov AV., Gamaleddin I, Sproule B, Rehm J. Naltrexone may block euphoria-like placebo effect. BMJ Case Reports 2013. Online Journal. [PMID: 23925860] doi:10.1136/bcr-2013-010098.
    https://www.ncbi.nlm.nih.gov/pubmed/23925680
  22. Shield KD, Samokhvalov AV., Rehm J.  Global burden of tuberculosis and lower respiratory infections attributable to alcohol consumption in 2004.  International Journal of Alcohol and Drug Research 2013, 2(1):11-8. doi:10.7895/ijadr.v2i1.49.
    http://www.ijadr.org/index.php/ijadr/article/view/49
  23. Katt M, Chase C, Samokhvalov AV., Argento E, Rehm J, Fischer B. Feasibility and outcomes of a community-based taper-to-low-dose-maintenance suboxone treatment program for prescription opioid dependence in a remote First Nations community in Northern Ontario. Journal of Aboriginal Health 2012, 9(1):52-9.
    https://journals.uvic.ca/index.php/ijih/article/view/12394
  24. Lachenmeier DW, Monakhova YB, Samokhvalov AV., Rehm J.  Causality between polyhexamethyleneguanidine occurrence in unrecorded alcohol and cholestatic hepatitis outbreak in Russia.  Clinical Toxicology 2012, 50(2):154-5. [PMID: 22216917] doi:10.3109/15563650.2011.646355
    https://www.ncbi.nlm.nih.gov/pubmed/22216917
  25. Solodun YV, Monakhova YB, Kuballa T, Samokhvalov AV., Rehm J, Lachenmeier DW. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks.  Interdisciplinary Toxicology 2011, 4(4): 101-8. [PMID: 22319254]. doi:10.2478/v10102-011-0030-x
    https://www.ncbi.nlm.nih.gov/pubmed/22319254
  26. Lachenmeier DW, Samokhvalov AV., Leitz J, Schoeberl K, Kuballa T, Linskiy IV, Minko OI, Rehm J.  The composition of unrecorded alcohol from Eastern Ukraine: is there a toxicological concern beyond ethanol alone?  Food and Chemical Toxicology 2010, 48(10):2842-7. [PMID: 20638436] doi: 10.1016/j.fct.2010.07.016
    https://www.ncbi.nlm.nih.gov/pubmed/20638436
  27. Samokhvalov AV., Irving HM, Rehm J.  Alcohol as a risk factor for atrial fibrillation: a systematic review and meta-analysis. European Journal of Cardiovascular Prevention and Rehabilitation 2010, 17(6):706-12. [PMID: 21461366] doi: 10.1097/HJR.0b013e32833a1947
    https://www.ncbi.nlm.nih.gov/pubmed/21461366
  28. Samokhvalov AV., Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: systematic review and meta-analysis. Epidemiology and Infection 2010, 138(12), 1789-95. [PMID: 20380771] doi:10.1017/S0950268810000774
    https://www.ncbi.nlm.nih.gov/pubmed/20380771
  29. Samokhvalov AV., Popova S, Room R, Ramonas M, Rehm J. Disability associated with alcohol abuse and dependence.  Alcoholism: Clinical and Experimental Research 2010, 34(11), 1871-1878. [PMID: 20662803] doi:10.1111/j.1530-0277.2010.01275.x
    https://www.ncbi.nlm.nih.gov/pubmed/20662803
  30. Samokhvalov AV., Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: a systematic review and meta-analysis. Epilepsia 2010, 51(7):1177-84. [PMID: 20074233]
  31. Rehm J, Baliunas D, Borges GLG, Graham K, Irving H, Parry CD, Patra J, Poznyak V, Roerecke M, Room R, Taylor B, Samokhvalov AV., Popova S. The relation between different dimensions of alcohol consumption and burden of disease – an overview. Addiction 2010, 105(5):817-843. [PMID: 20331573] doi: 10.1111/j.1360-0443.2010.02899.x
    https://www.ncbi.nlm.nih.gov/pubmed/20331573
  32. Rehm J, Samokhvalov AV., Neuman, MG., Room R, Parry CD, Lönroth K, Patra J, Poznyak V, Popova S. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009, 9(1):450. [PMID:19961618] doi:10.1186/1471-2458-9-450
    https://www.ncbi.nlm.nih.gov/pubmed/19961618
  33. Irving HM, Samokhvalov AV., Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and Meta-analysis. J Pancreas 2009, 10(4):387-92. [PMID: 19581740]
    https://www.ncbi.nlm.nih.gov/pubmed/19581740
  34. Samokhvalov AV., Pidkorytov VS, Linskiy IV, Minko OI, Minko OO, Rehm J, Popova S. Alcohol use and addictions service in Ukraine. International Psychiatry 2009, 6(1):5-7.
    Available through: http://www.psychiatry.ua/eng/eng049.htm
  35. Gavenko VL, Synaiko VL, Mozgovaya TP, Samokhvalov AV. Соматоформная вегетативная дисфункция сердца и сердечно-сосудистой системы – актуальность исследований и сопутствующие проблемы [Somatoform autonomic dysfunction of heart and cardiovascular system – topicality of research projects and concomitant problems]. Український вісник психоневрології [Ukrainian Bulletin of Psychoneurology] 2007, 15(1):64-6.
  36. Samokhvalov AV. Клинико-психопатологические особенности соматоформной вегетативной дисфункции сердца и сердечно-сосудистой системы (F45.30) у лиц молодого возраста [Clinico-psychopathological peculiarities of somatoform vegetative dysfunction of heart and cardiovascular system (F45.30) in young patients]. Український вісник психоневрології [Ukrainian Bulletin of Psychoneurology] 2006, 14(3):51-4.
  37. Samokhvalov AV. Психофизиологические особенности студентов с соматоформной вегетативной дисфункцией сердца и сердечно-сосудистой системы [Psychophysiological features of students with somatoform autonomic dysfunction of heart and cardiovascular system]. Експериментальна і клінічна медицина [Experimental and Clinical Medicine ] 2006, 51(4):115-9.
  38. Samokhvalov AV Особенности личности больных с соматоформной вегетативной дисфункцией сердца и сердечно-сосудистой системы (F45.30) [Features of personality in patients with somatoform autonomic dysfunction of heart and cardiovascular system (F45.30)]. Експериментальна і клінічна медицина [Experimental and Clinical Medicine] 2006, 51(1):140-3.
  39. Gavenko VL, Synaiko VL, Mozgovaya TP, Samokhvalov AV. Клинико-анамнестические особенности студентов с соматоформной вегетативной дисфункцией сердца и сердечно-сосудистой системы [Clinical-anamnestic features in students with somatoform autonomic dysfunction of heart and cardiovascular system]. Медицина сегодня и завтра [Medicine today and tomorrow] 2006, 3-4:144-9.
  40. Samokhvalov AV. Патогенетическая модель развития соматоформной вегетативной дисфункции сердца и сердечно-сосудистой системы (F45.30) у лиц молодого возраста [Pathogenetic model of development of somatoform autonomic dysfunction of heart and cardiovascular system (F45.30) in youth]. Архів Психіатрії [Archive of Psychiatry] 2006, 12(1-4):88-92.
  41. Samokhvalov AV. Взаимосвязь степени выраженности вегетативных нарушений и уровня тревожности у больных соматоформной вегетативной дисфункцией (F45.3) [Correlation between intensity of autonomic disorders and anxiety level in patients with somatoform autonomic disorder (F45.3)]. Медицина сегодня и завтра [Medicine today and tomorrow] 2005; 4:84-9.
  42. Samokhvalov AV. Структура вегетативных нарушений у больных с соматоформной вегетативной дисфункцией (F45.3) [Structure of vegetative disorders in patients with somatoform autonomic disorder]. Український вісник психоневрології [Ukrainian Bulletin of Psychoneurology] 2005,13(4):60-4.
  43. Letters to the editor and commentaries in Peer-Reviewed journals

  44. Samokhvalov AV, Rehm J. Premature mortality in epilepsy and the role of psychiatric comorbidity. Lancet 2014, 383(9916):511. [PMID: 24506902] doi:10.1016/S0140-6736(14)60179-3. https://www.ncbi.nlm.nih.gov/pubmed/24506902
  45. Rehm J, Anderson P, Gual A, Kraus L, Marmet S, Nutt DJ, Room R, Samokhvalov AV., Scafato E, Shield KD, Trapencieris M, Wiers RW, Gmel G. The tangible common denominator of substance use disorders: A reply to commentaries to Rehm et al. (2013a). Alcohol and Alcoholism 2014, 49(1):118-122. doi:10.1186/1617-9625-12-19
    https://www.ncbi.nlm.nih.gov/pubmed/25745380
  46. Rehm J, Gmel G, Hasan OSM, Imtiaz S, Popova S, Probst C, Roerecke M, Room R, Samokhvalov AV., Shield KD, Shuper PA. The contribution of unrecorded alcohol to health harm. Addiction 2017, 112(9):1687-8. doi:10.1111/add.13865
    https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13865
  47. Books and monographs

  48. Langlois KA, Samokhvalov AV., Rehm J, Spence ST, Connor Gorber SK. Health state descriptions for Canadians: Mental illnesses. Ottawa, Statistics Canada, 2011. ISBN 978-1-100-19649-7
  49. Langlois KA, Samokhvalov AV., Rehm J, Spence ST, Connor Gorber SK. Descriptions des états de santé au Canada: Maladies mentales. Ottawa, Statistique Canada, 2011. ISBN : 978-1-100-98278-6
  50. Samokhvalov AV. The Science of Physiognomy: Physiometric Analysis. Kharkiv, Ukraine: Новое Слово, 2003. ІSBN 966-8430-04-2
  51. Samokhvalov AV. Визуальный Психоанализ [Visual Psychoanalsysis]. Kharkiv, Ukraine: Новое Слово, 2003. ISBN: 966-96167-7-8
  52. Book Chapters

  53. Selby P, Samokhvalov AV. Ballarino V. Bupropion. In: Els C, Kunyk D, Selby P. (Eds.) Disease Interrupted: A clinical guide to tobacco reduction and cessation (pp.199-216).  Toronto: Centre for Addiction and Mental Health, 2018. ISBN: 978-1-77114-385-1.
  54. Selby P, Samokhvalov AV. Sustained-Release Bupropion. In: Els C, Kunyk D, Selby P. (Eds.) Disease Interrupted: Tobacco Reduction and Cessation (pp.181-8). Québec, Québec: Les Presses De L’Université Laval, 2014. ISBN: 2-7637-1989-9.
  55. Selby P, Samokhvalov AV. Bupropion à liberation prolongée. In: Els C, Kunyk D, Selby P., Filimon M. (Eds.), Écraser La Maladie. Réduction Et Abandon Du Tabagisme (pp.209-17). Québec, Québec: Les Presses De L’Université Laval, 2014. ISBN: 9782763719863.
  56. Samokhvalov AV., Farid Araki K, Selby P, Rehm J. Alcohol-related seizure disorders. In: Reuber M, Schachter SC (Eds.) Borderland of Epilepsy Revisited (pp.144-54). Oxford University Press, New York, 2013. ISBN: 9780199796793.
  57. Samokhvalov AV., Shuper PA, Rehm J. Infectious Disease. In: Boyle P, Boffetta P, Lowenfels AB, Burns H, Brawley O, Zatonski W, Rehm J (Eds) Alcohol: Science, Policy, and Public Health (pp.300-6). Oxford University Press, Oxford 2013. ISBN: 978‐0‐19‐965578‐6.
  58. Samokhvalov AV., Rehm J. Heroin Addiction. In Miller PM (Ed.) Principles of Addiction. Comprehensive Addictive Behaviours and Disorders, Volume I (pp.657-67). San Diego: Academic press, 2013. ISBN: 978-0-12-398336-7.
  59. Selby P, Samokhvalov AV. Sustained-Release Bupropion. In Els C, Kunyk D, Selby P. (Eds.), Disease Interrupted: Tobacco Reduction and Cessation (pp.153-161). Charleston, SC: CreateSpace Independent Publishing Platform, 2012. ISBN: 978-1467912938.
  60. Patra J, Samokhvalov AV., Rehm J. Epidemiology of alcohol abuse: Extent and nature of the problem.  In H. Ghodse, H. Herrman, M. Maj, & N. Sartorius (Eds.), Substance abuse disorders. West Sussex, UK: John Wiley, 2011. ISBN: 9780470745106.
  61. Abstracts published in peer-reviewed journals

  62. Samokhvalov AV., Awan S, Probst C, Voore P, Rehm J. Clinical outcomes of the DA VINCI Project. European Psychiatry 2018; 48S:S165-6.
  63. Samokhvalov AV., Rehm J. Triple-blind randomized placebo-controlled clinical trial of oral naloxone for opioid-induced constipation in patients with opioid use disorder receiving methadone maintenance treatment. European Psychiatry 2018; 48S:S393.
  64. Samokhvalov AV. Awan S, George TP, Le Foll B, Probst C, Voore P, Rehm J. Clinical Outcomes of the Integrated Care Pathway for Concurrent Major Depressive and Alcohol Use Disorders: A Review of the First Two Years. Alcoholism: Clinical and Experimental Research 2017; 41(S1):230A.
  65. Samokhvalov AV. Awan S, Le Foll B, Probst C, Voore P, Rehm J. Clinical outcomes of the first 2 years of implementation of the integrated care pathway for concurrent major depressive disorder and alcohol use disorder. European Psychiatry 2017; 41:S79.
  66. Samokhvalov AV, Sproule B, Selby P, Rehm J. Oral Naloxone for Methadone-induced Constipation: Preliminary Results of a Randomized Placebo-Controlled Trial. European Psychiatry 2015; 30(S1):1919.
  67. Samokhvalov AV, Awan S, Voore P. Early Outcomes of the Integrated Care Pathway for Concurrent Major Depressive Disorder and Alcohol Dependence. European Psychiatry 2015; 30(S1):1088.
  68. Other publications

  69. Samokhvalov AV. “Reverence for life: ethics of the XXI century’s physician” in Young medics about Albert Schweitzer, Warsaw, Poland, 2001.
  70. Online resources

  71. Portico webpage on the DA VINCI methodology and tools:
    https://www.porticonetwork.ca/web/davinci
  72. Samokhvalov AV. Webinar: Phenibut Use Disorder: What is it and how we can help? Provincial System Support Program, CAMH, Toronto, Ontario, Canada, Aired on April 5th, 2018. Accessible via:
    https://www.eventbrite.com/e/phenibut-use-disorder-what-is-it-and-how-we-can-help-tickets-42364568565
  73. MacArthur T, Samokhvalov AV., Awan S. Webinar: A New Reality, a New Way: Treating major depression and alcohol dependence together. CFHI, Toronto, Ontario, Canada, September 19th, 2016.
    https://www.cfhi-fcass.ca/WhatWeDo/on-call/a-new-reality-a-new-way-treating-major-depression-and-alcohol-dependence-together
  74. Lectures and Presentations

  75. Samokhvalov AV. Integrated treatment for concurrent disorders: the DA VINCI project. UCLA, California, Los Angeles, Feb 15th, 2018
  76. Samokhvalov AV. Webinar: Phenibut Use Disorder: What is it and how we can help? Provincial System Support Program, CAMH, Toronto, Ontario, Canada, Aired on April 5th, 2018. Accessible via:
    https://www.eventbrite.com/e/phenibut-use-disorder-what-is-it-and-how-we-can-help-tickets-42364568565
  77. Samokhvalov AV.. Integrated treatment for concurrent depression and alcohol use disorder – can the DA VINCI model be used in a community hospital? Markham-Stouffville Hospital, Markham, Ontario, Canada, February 23rd, 2018.
  78. Samokhvalov AV. Invited Lecture: The DA VINCI project: Implementation of an integrated treatment protocol across Ontario and its outcomes. McMaster University, Hamilton, Ontario, Canada, Presented on January 10th, 2018. Accessible via:
    https://psychiatry.mcmaster.ca/news-events/events/event/2018/01/10/default-calendar/department-of-psychiatry-behavioural-neurosciences-grand-rounds---andriy-samokhvalov
  79. Samokhvalov AV.. The DA VINCI Project: Developing, Implementing and Scaling Up an Integrated Care Pathway for Depression and Alcoholism. Keynote speaker: 10th Annual Addiction Day and Networking Fair, University of Calgary, Calgary, Alberta, Canada, June 1st, 2018.
  80. Samokhvalov AV. Von Nagel J, Awan S, Voore P. Symposium: Integrated Care Pathways in Mental Health and Addictions. International Congress on Dual Disorders, Madrid, Spain, March 26th, 2017
  81. Samokhvalov AV., Awan S, Simmons J, Kloiber S, Foussias G, Voore P. Symposium: Canadian Psychiatric Association Annual Conference, Ottawa, Canada, September 15th, 2017.
  82. Samokhvalov AV., Awan S. The DA VINCI Project: Implementing and Evaluating the CAMH Integrated Care Pathway for Concurrent Major Depressive and Alcohol Use Disorders at William Osler Health System. William Osler Health System, Brampton, Ontario, Canada, February 15th, 2017.
  83. Samokhvalov AV., Awan S. The DA VINCI Project Outcomes: Scaling up the CAMH Integrated Care Pathway for Concurrent Major Depressive and Alcohol Use Disorders. CAMH, April 20th, 2017.
  84. Samokhvalov AV.. The evolution of the DA VINCI project at CAMH and evaluation of its outcomes, CAMH, Toronto, Ontario, Canada, Mar 15th, 2017
    https://www.porticonetwork.ca/web/events/evolution-davinci
  85. Samokhvalov AV. How to best treat patients with co-morbid substance use and mental disorders? The concept of integrated care pathway, and results from a provincial implementation in Ontario, Canada. Dresden University, Dresden, Germany, October 26th, 2016
  86. Samokhvalov AV. The development of an integrated ambulatory treatment program for patients with depression and alcohol dependence. Academic Medical Center, University of Amsterdam, Amsterdam, October 25th, 2016.
  87. Samokhvalov AV. DA VINCI: Integrating care for better outcomes in concurrent depression and alcohol use disorder. TEDx Talk, Vaughan, Ontario, Canada. September 19th, 2016.
  88. Samokhvalov AV.Integrated Treatment for Concurrent Major Depressive Disorder and Alcohol Use Disorder, Hospital Clinic of Barcelona, Barcelona, Spain, September 14th, 2016.
  89. Samokhvalov AV.. Treating Co-Morbid Alcohol Use and Mood Disorders. Invited lecture: CANMAT conference “Depression Guidelines 2016 and Psychopharmacology Update”, University of Toronto, Toronto, Ontario, Canada, November 26th, 2016.
  90. Voore P, Awan S, Rajji T, Colins A, Samokhvalov AV.. Symposium: Integrated Care Pathways: Reducing Unnecessary Variations in Care in Mental Health and Addictions. Waypoint Research Institute 2015, Barrie, Ontario, Canada, June 17th, 2016
  91. LaForme B. Samokhvalov AV., Awan S. Symposium: The DA VINCI Project: Depression And Alcoholism - Validation Of An Integrated Care Initiative. 17th Canadian Collaborative Mental Health Care Conference, Kelowna, British Columbia, Canada, June 18th, 2016
  92. MacArthur T, Samokhvalov AV., Awan S. Webinar: A New Reality, a New Way: Treating major depression and alcohol dependence together. CFHI, Toronto, Ontario, Canada, September 19th, 2016.
    https://www.cfhi-fcass.ca/WhatWeDo/on-call/a-new-reality-a-new-way-treating-major-depression-and-alcohol-dependence-together
  93. Samokhvalov AV., Awan S. Integrated care pathway for major depressive disorder and alcohol dependence - Experiences from our first year. Addictions Rounds, CAMH, Toronto, Ontario, Canada, May 15th, 2015.
    http://eenet.ca/resource/addiction-rounds-integrated-care-pathway-major-depressive-disorder-and-alcohol-dependence
  94. Oral communications and posters

  95. Samokhvalov AV., Awan S, Probst C, Voore P, Rehm J. Clinical outcomes of the DA VINCI Project. European Psychiatric Association, Nice, France, March 2018 
  96. Samokhvalov AV., Rehm J. Triple-blind randomized placebo-controlled clinical trial of oral naloxone for opioid-induced constipation in patients with opioid use disorder receiving methadone maintenance treatment. European Psychiatric Association, Nice, France, March 2018
  97. Samokhvalov AV. Awan S, George TP, Le Foll B, Probst C, Voore P, Rehm J. Clinical Outcomes of the Integrated Care Pathway for Concurrent Major Depressive and Alcohol Use Disorders: A Review of the First Two Years. Research Society on Alcoholism, Denver, Colorado, USA, June 2017
  98. Samokhvalov AV. Awan S, George TP, Le Foll B, Probst C, Voore P, Rehm J. The DA VINCI Project: Outcomes of the Multi-Site Implementation of the CAMH Integrated Care Pathway for Major Depressive and Alcohol Use Disorders. Canadian Psychiatric Association, Ottawa, Ontario, Canada, September 14th, 2017.
  99. Palandra A, Awan S, Samokhvalov AV.. An Integrated Care Pathway (ICP) for Major Depressive Disorder and Alcohol Use Disorder. 78th CPA National Convention, Toronto, Ontario, Canada, June 10th, 2017.
  100. Solomon R, Awan S, Samokhvalov AV.. DA VINCI: Depression and Alcoholism – Validation of an Integrated Care Initiative, CAHO, November 23rd, 2017.
  101. Awan S, Samokhvalov AV.. DA VINCI: Journey of a QI initiative, University of Toronto, Toronto, Ontario, Canada, March 4th, 2017.
  102. Samokhvalov AV.. DA VINCI Evaluation and Impact: The Evolution of DA VINCI. DA VINCI EOP Meeting, Toronto, Ontario, Canada, January 19th, 2017.
  103. Awan S, Samokhvalov AV., Voore P. The DA VINCI Project: Scaling up an Effective Integrated Care Pathway. Canadian Psychiatric Association, Toronto, Ontario, Canada, September 24th, 2016.
  104. Samokhvalov AV., Awan S, Carpenter A, Le Foll B, Voore P. Integrated Treatment for Concurrent Major Depressive Disorder and Alcohol Use Disorder. Canadian Psychiatric Association, Toronto, Ontario, Canada, September 22nd, 2016.
  105. Samokhvalov AV., Sproule B, Selby P, Rehm J. Oral Naloxone for Methadone-induced Constipation: Preliminary Results of a Randomized Placebo-Controlled Trial. European Psychiatric Association, Barcelona, Spain, 2015
  106. Samokhvalov AV., Awan S, Voore P. Early Outcomes of the Integrated Care Pathway for Concurrent Major Depressive Disorder and Alcohol Dependence. European Psychiatric Association, Barcelona, Spain, 2015.
  107. Chaiton M, Mercredy G, Rehm J, Samokhvalov AV. Proximity to a tobacco retail outlet and smoking behaviour among clients of a nicotine dependence clinic. Society for Research on Nicotine and Tobacco.  Seattle, Washington, USA, 2014.
  108. Awan S, Voore P, Quilty L, Samokhvalov AV., Le Foll B. Developing and implementing an Integrated Care Pathway for comorbid depression and alcohol dependence. 15th Canadian Collaborative Mental Health Care Conference, Toronto, Ontario, Canada, 2014
  109. Pidkorytov VS, Samokhvalov AV, Serykova OI. Epidemiology of mental disorders in Ukraine in 1970-2005. XXV Congress of Latin American Psychiatric Association, Isla De Margarita, Venezuela, 2008.
  110. Pidkorytov VS, Samokhvalov AV, Serykova OI. Dynamics of statistical indices of registered morbidity of major groups of mental disorders in Ukraine in 1970-2005. ENMESH, Krakow, Poland, 2008.
  111. Samokhvalov AV. Особенности интеллектуальной работоспособности у больных соматоформнмной вегетативной дисфункцией сердца и сердечно-сосудистой системы [Cognitive performance in patients with somatoform autonomic dysfunction of heart and cardiovascular system]. Annual inter-institutional conference of young scientists «Медицина третього тисячоліття [Medicine of the third Millennium]»; Kharkiv, Ukraine, 2007.
  112. Samokhvalov AV. Наследственные предикторы развития соматоформной вегетативной дисфункции сердца и сердечно-сосудистой системы у лиц молодого возраста [Hereditary predictors of somatoform vegetative dysfunction of heart and cardiovascular system in youth]. Annual inter-institutional conference of young scientists «Медицина третього тисячоліття [Medicine of the third Millennium]»; Kharkiv, Ukraine, 2007.
  113. Samokhvalov AV, Grechanina YB. Риск развития соматоформной вегетативной дисфункции сердца и сердечно-сосудистой системы у лиц молодого возраста с отягощенным анамнезом [Risk of somatoform vegetative dysfunction in young patients with complicated history]. Annual inter-institutional conference of young scientists «Медицина третього тисячоліття [Medicine of the third Millennium]»; Kharkiv, Ukraine, 2007.
  114. Samokhvalov AV. Pathogenetical mechanisms of Somatoform Autonomic Dysfunction (F45.3X) in Students. WPA International Congress of Psychiatry, Caracas, Venezuela, 2006.
  115. Samokhvalov AV. Psychophysiological features of patients with neurocirculatory dystonia. WPA International Congress, Florence, Italy, 2004.
  116. Samokhvalov AV. Психічні порушення у хворих із функціональними розладами вегетативної нервової системи [Mental disorders in patients with functional disorders of autonomic nervous system]. Annual conference «Досягнення молодих вчених – майбутнє України [Achievements of young scientists – Future of Ukraine]»; Kharkiv, Ukraine, 2004.
  117. Samokhvalov AV. От антропометрии и физиогномики к физиометрической диагностике личности [From anthropometry and physiognomy to physiometric psychodiagnostics]. Annual inter-institutional conference of young scientists «Медицина третього тисячоліття [Medicine of the third Millennium]»; Kharkiv, Ukraine, 2003.
  118. Samokhvalov AV. Psychosomatical correlates of the educational stress in medical students. XII WPA Congress, Yokogama, Japan, 2002.
  119. Samokhvalov AV.Физиометрический анализ [Physiometric analysis]. Pan-Ukrainian Conference «Валеологические и эниовалеологические аспекты адаптации и профилактики» [«Valeological and eniovaleological aspects of adaptation and prophylaxis»], Kharkiv, Ukraine, 2002
  120. Samokhvalov AV. Физиогномическая диагностика личности [Physiognomic diagnostics of personality]. Annual conference of young researchers «Актуальные проблемы современной психиатрии [Actual problems of contemporary psychiatry]»; Kharkiv, Ukraine, 2002.
  121. Samokhvalov AV. Методика фізіометричної психодіагностики [Physiometric method of psychodiagnostics]. Annual conference of young scientists of Kharkiv Medical Academy of Postgraduate Education; Kharkiv, Ukraine, 2002.
  122. Samokhvalov AV. Las manifestaciones fisiologicas y psicologicas de la adaptacion al estres de instruccion. [Psychophysiological manifestations of the adaptation to the educational stress]. WPA Congress, Madrid, Spain, 2001.
  123. Samokhvalov AV. Динамика психологической и физиологической адаптации студентов к учебным нагрузкам [Dynamics of psychological and physiological adaptation of students to educational loads]. Annual conference of young researchers «Актуальные проблемы современной психиатрии [Actual problems of contemporary psychiatry]»; Kharkiv, Ukraine, 2001.
  124. Samokhvalov AV., Morgulis MV, Revin VV. Социально-психологическое факторы учебной адаптации у студентов-медиков [Social-psychological factors of educational adaptation of medical students]. Annual conference of young researchers «Актуальные проблемы современной психиатрии [Actual problems of contemporary psychiatry]»; Kharkiv, Ukraine, 2000.
  125. Samokhvalov AV. Личность и внешность [Personality and appearance]. Annual conference of young researchers «Актуальные проблемы современной психиатрии [Actual problems of contemporary psychiatry]»; Kharkiv, Ukraine, 1999.
  126. Media appearances

  127. Samokhvalov AV.Treatment of concurrent depression and alcohol use disorder. TEDx Vaughan, Ontario, Canada, Sep 19th, 2016
    https://www.youtube.com/watch?v=Y126Cat5DKY&list=PL5ST5rg6nCx2V60-4Q0HNhJCwnWqbwX3b&index=8
  128. van Zelm R. Inaugural pathways conference Canadian National Section, EPA News, March 9th, 2015
    http://e-p-a.org/news/inaugural-pathways-conference-canadian-national-section/
  129. van Zelm R. New National Section: Canada, EPA News, May 1st, 2015
    http://e-p-a.org/2015/05/
  130. Rings on Fire, a documentary on rampant opioid use disorder in aboriginal communities in Northern Ontario, Canada.
    https://www.youtube.com/watch?v=lgFJm45ZVJQ&vl=en
  131. Community meeting with MPP Cristina Martins, Toronto, Ontario, Canada, November 13th, 2014.
    http://thenewspaper.ca/the-inside/new-clinic-facing-backlash-harm-reduction-methods/
  132. CAMH News: Physician of the Year Award
    http://2017.camh.ca/en/hospital/about_camh/newsroom/CAMH_in_the_headlines/stories/Pages/CAMH-Medical-Staff-Association-Physician-of-the-Year,-Andriy-Samokhvalov.aspx
  133. CAMH News: CAMH creates a new way to help clients with depression and alcohol use
    http://2017.camh.ca/en/hospital/about_camh/newsroom/CAMH_in_the_headlines/stories/Pages/Integrated-Care-Pathways.aspx